ImmuCell Corp

ICCC14 Dec 2024
Healthcare
$4.58
+0.06 (+6.03%)
Lowest Today
$4.58
Highest Today
$5.03
Today’s Open
$4.58
Prev. Close
$4.64
52 Week High
$5.82
52 Week Low
$3.34
To Invest in ImmuCell Corp

ImmuCell Corp

Healthcare
ICCC14 Dec 2024
+0.06 (+6.03%)
1M
3M
6M
1Y
5Y
Low
$4.58
Day’s Range
High
$5.03
4.58
52 Week Low
$3.34
52-Week Range
52 Week High
$5.82
3.34
1 Day
-
1 Week
-3.23%
1 month return
+32.77%
3 month return
+29.53%
6 month return
+3.46%
1 Year return
-0.2%
3 Years return
-43.09%
5 Years return
-9.81%
10 Years return
-
Institutional Holdings
Cresset Asset Management, LLC
2.96
Vanguard Group Inc
2.53
Vanguard Total Stock Mkt Idx Inv
1.78
Renaissance Technologies Corp
1.68
Bleichroeder LP
1.14
Dimensional Fund Advisors, Inc.
0.82
Vanguard Institutional Extnd Mkt Idx Tr
0.75

Market Status

Fundamentals
Market Cap
32.08 mln
PB Ratio
1.53
PE Ratio
0
Enterprise Value
52 mln
Total Assets
43.81 mln
Volume

Company Financials

Fund house & investment objective

Company Information
ImmuCell Corporation, an animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally. The company operates through two segments, Scours and Mastitis. It offers First Defense, an orally delivered scours preventive product for calves with claims against E. coli, coronavirus, and rotavirus; and Tri-Shield First Defense, a passive antibody product for the treatment of E. coli, coronavirus, and rotavirus. The company also provides California Mastitis Test, a quick on-farm diagnostic that is used to detect somatic cell counts in milk, as well as to determine, which quarter of the udder is mastitic; and Dual-Force First Defense, a bivalent gel tube formulation. In addition, it is developing Re-Tain Drug Product, a Nisin-based intramammary treatment of subclinical mastitis in lactating dairy cows. It sells its products through animal health distributors. ImmuCell Corporation was incorporated in 1982 and is headquartered in Portland, Maine.
Organisation
ImmuCell Corp
Employees
75
Industry
Biotechnology
CEO
Mr. Michael F. Brigham
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:

Take your next step